» Articles » PMID: 34262013

Real-world Evidence for Improved Outcomes with Histamine Antagonists and Aspirin in 22,560 COVID-19 Patients

Overview
Date 2021 Jul 15
PMID 34262013
Citations 15
Authors
Affiliations
Soon will be listed here.
Citing Articles

Analyzing Prescribing Trends of Gastric Acid Suppressants in the UK Using Segmented Regression: Evaluating the Influence of COVID-19 (2019-2024).

Orayj K Healthcare (Basel). 2025; 13(5).

PMID: 40077005 PMC: 11898435. DOI: 10.3390/healthcare13050442.


Comparison of the risk of hospital admission, need for ventilation, sepsis, pneumonitis and death among the recent monkeypox outbreak and historical outbreaks.

Gaertner F, Preissner S, Petri Jr W, Atolani O, Heiland M, Nahles S BMC Infect Dis. 2023; 23(1):610.

PMID: 37723464 PMC: 10506253. DOI: 10.1186/s12879-023-08599-w.


Effectiveness of famotidine on the risk of poor prognosis in patients with COVID-19: A nationwide cohort study in Korea.

Kwon R, Kim H, Lee S, Koyanagi A, Shin J, Song T Heliyon. 2023; 9(6):e16171.

PMID: 37287614 PMC: 10232936. DOI: 10.1016/j.heliyon.2023.e16171.


Antibiotics Significantly Decrease the Survival of Head and Neck Carcinoma Patients with Immunotherapy: A Real-World Analysis of More Than 3000 Cases.

Preissner S, Heiland M, Preissner R, Wirth M, Wollenberg B Cancers (Basel). 2023; 15(8).

PMID: 37190270 PMC: 10136869. DOI: 10.3390/cancers15082342.


Drug Repurposing Using Gene Co-Expression and Module Preservation Analysis in Acute Respiratory Distress Syndrome (ARDS), Systemic Inflammatory Response Syndrome (SIRS), Sepsis, and COVID-19.

Mailem R, Tayo L Biology (Basel). 2022; 11(12).

PMID: 36552336 PMC: 9775208. DOI: 10.3390/biology11121827.


References
1.
Mura C, Preissner S, Preissner R, Bourne P . A Birds-Eye (Re)View of Acid-Suppression Drugs, COVID-19, and the Highly Variable Literature. Front Pharmacol. 2021; 12:700703. PMC: 8385362. DOI: 10.3389/fphar.2021.700703. View

2.
Loucera C, Esteban-Medina M, Rian K, Falco M, Dopazo J, Pena-Chilet M . Drug repurposing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection. Signal Transduct Target Ther. 2020; 5(1):290. PMC: 7729141. DOI: 10.1038/s41392-020-00417-y. View

3.
Freedberg D, Conigliaro J, Wang T, Tracey K, Callahan M, Abrams J . Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study. Gastroenterology. 2020; 159(3):1129-1131.e3. PMC: 7242191. DOI: 10.1053/j.gastro.2020.05.053. View

4.
Hogan Ii R, Hogan Iii R, Cannon T, Rappai M, Studdard J, Paul D . Dual-histamine receptor blockade with cetirizine - famotidine reduces pulmonary symptoms in COVID-19 patients. Pulm Pharmacol Ther. 2020; 63:101942. PMC: 7455799. DOI: 10.1016/j.pupt.2020.101942. View

5.
Ennis M, Tiligada K . Histamine receptors and COVID-19. Inflamm Res. 2020; 70(1):67-75. PMC: 7673069. DOI: 10.1007/s00011-020-01422-1. View